Loading...

New Capacity And R&D Focus Will Accelerate Renewable Transition

Published
05 Dec 24
Updated
09 Oct 25
AnalystConsensusTarget's Fair Value
€72.75
31.3% undervalued intrinsic discount
09 Oct
€50.00
Loading
1Y
-40.2%
7D
-2.3%

Author's Valuation

€72.7531.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on09 Oct 25
Fair value Decreased 4.35%

Arkema's analyst price target has been revised downward from €76.06 to €72.75. This change reflects analysts' expectations for slower revenue growth and a higher discount rate, even though profit margins have seen slight improvement.

Shared on25 Sep 25
Fair value Decreased 1.30%

Analysts have trimmed Arkema’s price target to €76.06, reflecting heightened caution around 2025 guidance cuts, persistent margin pressure, and weaker end-market demand, despite some confidence in the company’s long-term positioning. Analyst Commentary Bearish analysts cite increased risk of significant 2025 guidance cuts, particularly ahead of Q2 results.

Shared on01 May 25
Fair value Decreased 20%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 2.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 24%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 22%

Shared on26 Mar 25
Fair value Decreased 0.43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Decreased 5.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.